
Chemistry
A sustainable synthesis of the SARS-CoV-2 Mpro inhibitor nirmatrelvir, the active ingredient in Paxlovid
J. R. A. Kincaid, J. C. Caravez, et al.
This groundbreaking research by Joseph R. A. Kincaid, Juan C. Caravez, Karthik S. Iyer, Rahul D. Kavthe, Nico Fleck, Donald H. Aue, and Bruce H. Lipshutz unveils a new 7-step synthetic approach to nirmatrelvir, the key component in Paxlovid, achieving an impressive 70% overall yield while utilizing green technology.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.